These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25194722)

  • 21. Increasing use of intravenous rt-PA does not affect safety in acute stroke.
    Pfefferkorn T; Liebetrau M; Müllner A; Bender A; Hamann GF
    J Neurol; 2005 Dec; 252(12):1500-3. PubMed ID: 16021352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008.
    Salam KA; Ummer K; Kumar VG; Noone ML; Laila A; Ragini J
    J Clin Neurosci; 2009 Oct; 16(10):1276-8. PubMed ID: 19570685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older.
    Zacharatos H; Hassan AE; Vazquez G; Hussein HM; Rodriguez GJ; Suri MF; Lakshminarayan K; Ezzeddine MA; Qureshi AI
    Am J Emerg Med; 2012 Jan; 30(1):158-64. PubMed ID: 21247724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
    Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
    Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke thrombolysis in England: an age stratified analysis of practice and outcome.
    Bray BD; Campbell J; Hoffman A; Tyrrell PJ; Wolfe CD; Rudd AG
    Age Ageing; 2013 Mar; 42(2):240-5. PubMed ID: 23174425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.
    Kunisawa S; Kobayashi D; Lee J; Otsubo T; Ikai H; Yokota C; Minematsu K; Imanaka Y
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):724-31. PubMed ID: 23910512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with recombinant tissue plasminogen activator in the management of intracardiac and arterial thrombosis in children.
    Olgun H; Buyukavci M; Ceviz N; Sahin IO; Yildirim ZK; Colak A; Tekgunduz KS; Caner I
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):726-30. PubMed ID: 24806322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.
    Kleindorfer D; Lindsell CJ; Brass L; Koroshetz W; Broderick JP
    Stroke; 2008 Mar; 39(3):924-8. PubMed ID: 18239184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside Represses Symptomatic Intracerebral Hemorrhage after Recombinant Tissue Plasminogen Activator Therapy by Promoting Transforming Growth Factor-β1.
    Chen J; Bai Q; Zhao Z; Sui H; Xie X
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):549-55. PubMed ID: 26683593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and outcomes of intravenous tissue plasminogen activator and endovascular thrombectomy utilization amongst pediatrics acute ischemic stroke.
    Malik P; Patel UK; Kaul S; Singla R; Kavi T; Arumaithurai K; Jani VB
    Int J Stroke; 2021 Feb; 16(2):172-183. PubMed ID: 32009581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prospects and predicaments of intravenous rt-PA in childhood ischemic stroke.
    Behrouz R
    Expert Rev Neurother; 2014 Mar; 14(3):255-9. PubMed ID: 24491039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
    El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I
    Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.
    Asaithambi G; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e42-5. PubMed ID: 22572162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
    Simon JE; Sandler DL; Pexman JH; Hill MD; Buchan AM;
    Age Ageing; 2004 Mar; 33(2):143-9. PubMed ID: 14960429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
    García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
    Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M; Diener HC; Kaste M; Mau J
    Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
    Li YH; Li MH; Zhao JG; Wang W
    J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous Thrombolysis and Risk Factors for Ischemic Stroke.
    Shrestha S; Poudel RS; Thapa LJ; Khatiwada D
    JNMA J Nepal Med Assoc; 2014; 52(193):745-50. PubMed ID: 26905561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.